News Daily News Whitehall II: Systolic BP Above 130 mm Hg at Age 50 Heightens Risk of Dementia L.A. McKeown June 13, 2018
News Conference News EuroPCR 2018 ‘Transient’ STEMI Patients Can Be Immediately Treated or Safely Deferred to Next Day Michael O'Riordan May 24, 2018
News Daily News Smartphone Heart Rate-Monitoring App Can Accurately Assess Ulnar Artery Patency Todd Neale April 03, 2018
News Daily News FDA Approves Resolute Onyx, Billed as Slimmest Stent Yet on US Market Yael L. Maxwell February 26, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Conference News AHA 2017 ‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18 Michael O'Riordan November 15, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Daily News Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force Michael O'Riordan October 11, 2017
News Features Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions Michael O'Riordan May 08, 2017
News Conference News ACC 2017 FDA Warns of Risk of Major Adverse Cardiac Events With Absorb BVS Michael O'Riordan March 18, 2017
News Daily News Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains L.A. McKeown January 09, 2017
News Daily News Absorb BVS Meets Performance Goal in Diabetic Patients, but Is It Enough to Justify a Broader Label? Yael L. Maxwell December 23, 2016
News Features The Bioresorbable Stent Story So Far: What Promise? What Price? Michael O'Riordan August 17, 2016
News Conference News TCT 2015 Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award October 12, 2015
News Daily News Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery Caitlin E. Cox June 15, 2015
News Daily News Halving DES Use in Low-Risk Patients Could Save $200 Million Annually Yael L. Maxwell July 11, 2012